首页 > 最新文献

Ayu最新文献

英文 中文
Efficacy of Vamana Karma (therapeutic emesis) followed by Darvyadi Kwatha (herbal decoction) in the management of prediabetes (Prameha) - A single-arm clinical trial. Vamana Karma(治疗性呕吐)和Darvyadi Kwatha(草药汤)治疗糖尿病前期(Prameha)的疗效——一项单臂临床试验。
Ayu
Pub Date : 2021-01-01 Epub Date: 2022-12-07 DOI: 10.4103/ayu.ayu_417_20
Uttamram Yadav, Santosh Kumar Bhatted

Background: Prediabetes is an alarming condition to control and prevent from developing diabetes mellitus which occurs due to the change in lifestyle and food habits. Timely untreated prediabetes turn into type-2 diabetes mellitus within a year and systemic complications such as retinopathy, nephropathy, and neuropathy could occur and in later stage multi system damage could take place.

Aims: The ai of this study is to evaluate the efficacy of Vamana Karma (therapeutic emesis) with Ikshuvaku Yoga and followed by oral administration of Darvyadi Kwatha (herbal decoction) in the management of prediabetes.

Materials and methods: After approval of IEC and registration under clinical trial registry of India, 20 patients suffering from prediabetes were registered in the trial. Diagnosis criteria were hemoglobin A1c (HBA1c), fasting blood sugar (FBS) and postprandial blood sugar (PPBS), and assessment criteria includes HBA1c, FBS, PPBS, along with improvement in Agnibala (strength of digestion and metabolism), Dehabala (physical strength) and Satvabala (mental strength), relief sign and symptom of prediabetes (Prameha), and improvement in quality of life (SF-36 Score). Classical Vamana Karma followed by oral administration of Darvyadi Kwatha was done. Total duration of treatment was 45 days and last follow-up was done on the 120th day. Student's t- test was used for the analysis of parametric data.

Results: After the treatment were observed that there is improvement in subjective as well as in objective parameters. Statistically highly significant result was observed in HBA1c (BT [day 0] Mean score 6.25 and AT [day 120] 5.63 [P < 0.001]), FBS (BT [day 0] mean score 120.05 and AT [day 120] 93.31 [P < 0.001]) and PPBS (BT [day 0] mean score 165.26 and AT [day 120] 112.84 [P < 0.001]), sign and symptoms of Prameha, Dehabala, Agnibala, Satvabala, and quality of life (SF-36 Score).

Conclusion: The present clinical study concludes that therapeutic emesis (bio purification) followed by Darvyadi Kwatha as internal medicine shows significant result in treating prediabetes (Prameha) safely and effectively also control and prevent developing diabetes mellitus. None of the patient converted to diabetes mellitus on the day 120.

背景:糖尿病前期是控制和预防糖尿病的一种令人担忧的情况,糖尿病是由于生活方式和饮食习惯的改变而发生的。及时治疗的糖尿病前期在一年内转变为2型糖尿病,可能发生视网膜病变、肾病和神经病变等系统并发症,后期可能发生多系统损伤。目的:本研究旨在评估Ikshuvaku瑜伽治疗呕吐的疗效,以及口服Darvyadi Kwatha(草药汤)治疗糖尿病前期的疗效。材料和方法:在IEC批准并在印度临床试验注册中心注册后,20名糖尿病前期患者在试验中注册。诊断标准为血红蛋白A1c(HBA1c)、空腹血糖(FBS)和餐后血糖(PPBS),评估标准包括HBA1c、FBS、PPBS,以及Agnibala(消化和代谢强度)、Dehabala(体力)和Satvabala(精神强度)的改善、糖尿病前期症状和体征的缓解(Prameha)以及生活质量的改善(SF-36评分)。完成了经典的Vamana Karma,然后口服Darvyadi Kwatha。治疗总持续时间为45天,最后一次随访于第120天。学生t检验用于参数数据的分析。结果:治疗后,观察到主观和客观参数均有改善。在HBA1c(BT[第0天]平均得分6.25和AT[第120天]5.63[P<0.001])、FBS(BT[第一0天]的平均得分120.05和AT[第一120天]93.31[P<0.01])和PPBS(BT[在第0天]平均得分165.26和AT[在第120天]的112.84[P<0.0001])、Prameha、Dehabala、Agnibala、Satvabala的体征和症状中观察到统计学上高度显著的结果,结论:本临床研究表明,Darvyadi Kwatha作为内科药物治疗性呕吐(生物净化)在安全有效地治疗糖尿病前期(Prameha)以及控制和预防糖尿病发展方面具有显著效果。在第120天,没有患者转变为糖尿病。
{"title":"Efficacy of <i>Vamana Karma</i> (therapeutic emesis) followed by <i>Darvyadi Kwatha</i> (herbal decoction) in the management of prediabetes (<i>Prameha</i>) - A single-arm clinical trial.","authors":"Uttamram Yadav,&nbsp;Santosh Kumar Bhatted","doi":"10.4103/ayu.ayu_417_20","DOIUrl":"10.4103/ayu.ayu_417_20","url":null,"abstract":"<p><strong>Background: </strong>Prediabetes is an alarming condition to control and prevent from developing diabetes mellitus which occurs due to the change in lifestyle and food habits. Timely untreated prediabetes turn into type-2 diabetes mellitus within a year and systemic complications such as retinopathy, nephropathy, and neuropathy could occur and in later stage multi system damage could take place.</p><p><strong>Aims: </strong>The ai of this study is to evaluate the efficacy of <i>Vamana Karma</i> (therapeutic emesis) with <i>Ikshuvaku Yoga</i> and followed by oral administration of <i>Darvyadi Kwatha</i> (herbal decoction) in the management of prediabetes.</p><p><strong>Materials and methods: </strong>After approval of IEC and registration under clinical trial registry of India, 20 patients suffering from prediabetes were registered in the trial. Diagnosis criteria were hemoglobin A1c (HBA1c), fasting blood sugar (FBS) and postprandial blood sugar (PPBS), and assessment criteria includes HBA1c, FBS, PPBS, along with improvement in <i>Agnibala</i> (strength of digestion and metabolism), <i>Dehabala</i> (physical strength) and <i>Satvabala</i> (mental strength), relief sign and symptom of prediabetes (<i>Prameha</i>), and improvement in quality of life (SF-36 Score). Classical <i>Vamana Karma</i> followed by oral administration of <i>Darvyadi Kwatha</i> was done. Total duration of treatment was 45 days and last follow-up was done on the 120<sup>th</sup> day. Student's <i>t</i>- test was used for the analysis of parametric data.</p><p><strong>Results: </strong>After the treatment were observed that there is improvement in subjective as well as in objective parameters. Statistically highly significant result was observed in HBA1c (BT [day 0] Mean score 6.25 and AT [day 120] 5.63 [<i>P</i> < 0.001]), FBS (BT [day 0] mean score 120.05 and AT [day 120] 93.31 [<i>P</i> < 0.001]) and PPBS (BT [day 0] mean score 165.26 and AT [day 120] 112.84 [<i>P</i> < 0.001]), sign and symptoms of <i>Prameha, Dehabala, Agnibala, Satvabala</i>, and quality of life (SF-36 Score).</p><p><strong>Conclusion: </strong>The present clinical study concludes that therapeutic emesis (bio purification) followed by <i>Darvyadi Kwatha</i> as internal medicine shows significant result in treating prediabetes (<i>Prameha</i>) safely and effectively also control and prevent developing diabetes mellitus. None of the patient converted to diabetes mellitus on the day 120.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9c/45/AYU-42-30.PMC9893903.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10663209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial. Aragvadhadi制剂的油和凝胶剂型与Rasayana Churna联合外用治疗白癜风的疗效——一项开放标记的比较临床试验。
Ayu
Pub Date : 2021-01-01 Epub Date: 2022-12-07 DOI: 10.4103/ayu.AYU_323_20
Sarika Makwana, Dipali Parekh, Prashant Bedarkar, Biswajyoti Patgiri

Introduction: Aragvadhadi Taila (ART) is one of the herbomineral formulations mentioned in Chakradatta indicated in Shwitra (vitiligo). Modification of Taila form into gel form reduces the risk of contamination in view of arsenical contents (Manahshila, Haratala) assures precise dose administration at desired site (by avoiding spreading). The gel is a comparatively acceptable dosage form than that of medicated oil.

Aim: The aim of the study is to evaluate the comparative efficacy of Aragvadhadi formulation in Taila (ART: Aragvadhadi Taila) and gel (ARG: Aragvadhadi gel) dosage forms with the internal administration of Rasayana Churna in the management of Shwitra.

Materials and methods: The study was a randomized open labeled, involving 66 patients of Shwitra that were randomly divided into two groups. Patients registered in group A (n = 34) were treated with local applications of ART and group B (n = 32) with ARG for 2 months. Rasayana Churna (3 g), along with the equal quantity of honey and Ghrita was given twice a day after the meal in both groups. Wilcoxon signed-rank test was applied to evaluate the effect of therapy in the individual group for subjective criteria like vitiligo area scoring index score, size and number of patches, Rukshata (dryness), Saparidaha (burning sensation), Bahalatva (thickening), Kandu (itching) while the comparison of results between the groups for the same by applying Coefficient of Variation (CV).

Results: Group B showed better and consistent results in all signs and symptoms except Rukshata, Saparidaha in terms of Coefficient of Variation. In both the groups, statistically highly significant improvement was found in signs and symptoms of Shwitra such as Saparidaha, Kandu, size of patches and number of patches; however, the difference between the groups was statistically insignificant.

Conclusion: Both the forms (ART, ARG) of Aragvadhadi formulation along with Rasayana Churna were found as a safe and effective treatment in vitiligo with significant pigment regeneration capacity as topical use for application over 2 months.

简介:Aragvadhadi Taila(ART)是Chakradatta中提到的用于Shwitra(白癜风)的草药制剂之一。鉴于砷含量,将Taila形式改为凝胶形式可降低污染风险(Manahshila,Haratala)确保在所需部位精确给药(避免扩散)。与药物油相比,这种凝胶是一种相对可接受的剂型。目的:本研究的目的是评估泰拉(ART:Aragvadhadi Taila)和凝胶(ARG:Aragvadhadi gel)剂型中的Aragvadadi制剂与Rasayana Churna内部给药在治疗Shwitra中的比较疗效。材料和方法:本研究是一项随机开放标记的研究,涉及66名Shwitra患者,他们被随机分为两组。A组(n=34)登记的患者接受局部应用ART治疗,B组(n=32)接受ARG治疗2个月。Rasayana Churna(3克)以及等量的蜂蜜和Ghrita在两组餐后每天服用两次。Wilcoxon符号秩检验用于评估个体组的治疗效果,主观标准包括白癜风面积评分指数得分、斑块大小和数量、Rukshata(干燥)、Saparidaha(烧灼感)、Baharatva(增厚)、Kandu(瘙痒),同时通过应用变异系数(CV)对各组之间的治疗结果进行比较。结果:在变异系数方面,B组除鲁克沙塔、萨帕力达外的所有体征和症状均表现出较好且一致的结果。在两组中,Shwitra的体征和症状(如Saparidaha、Kandu)、斑块大小和斑块数量均有统计学意义的显著改善;然而,两组之间的差异在统计学上并不显著。结论:两种形式(ART、ARG)的Aragvadhadi制剂与Rasayana Churna一起被发现是一种安全有效的白癜风治疗方法,具有显著的色素再生能力,可局部应用2个月以上。
{"title":"Efficacy of external application of oil and gel dosage forms of <i>Aragvadhadi</i> formulation in combination with <i>Rasayana Churna</i> in the management of <i>Shwitra</i> (vitiligo) - An open-labeled comparative clinical trial.","authors":"Sarika Makwana,&nbsp;Dipali Parekh,&nbsp;Prashant Bedarkar,&nbsp;Biswajyoti Patgiri","doi":"10.4103/ayu.AYU_323_20","DOIUrl":"10.4103/ayu.AYU_323_20","url":null,"abstract":"<p><strong>Introduction: </strong><i>Aragvadhadi Taila</i> (ART) is one of the herbomineral formulations mentioned in Chakradatta indicated in <i>Shwitra</i> (vitiligo). Modification of <i>Taila</i> form into gel form reduces the risk of contamination in view of arsenical contents (<i>Manahshila</i>, <i>Haratala</i>) assures precise dose administration at desired site (by avoiding spreading). The gel is a comparatively acceptable dosage form than that of medicated oil.</p><p><strong>Aim: </strong>The aim of the study is to evaluate the comparative efficacy of <i>Aragvadhadi</i> formulation in <i>Taila</i> (ART: <i>Aragvadhadi Taila</i>) and gel (ARG: <i>Aragvadhadi</i> gel) dosage forms with the internal administration of <i>Rasayana Churna</i> in the management of <i>Shwitra</i>.</p><p><strong>Materials and methods: </strong>The study was a randomized open labeled, involving 66 patients of <i>Shwitra</i> that were randomly divided into two groups. Patients registered in group A (<i>n</i> = 34) were treated with local applications of ART and group B (<i>n</i> = 32) with ARG for 2 months. <i>Rasayana Churna</i> (3 g), along with the equal quantity of honey and <i>Ghrita</i> was given twice a day after the meal in both groups. Wilcoxon signed-rank test was applied to evaluate the effect of therapy in the individual group for subjective criteria like vitiligo area scoring index score, size and number of patches, <i>Rukshata</i> (dryness), <i>Saparidaha</i> (burning sensation), <i>Bahalatva</i> (thickening), <i>Kandu</i> (itching) while the comparison of results between the groups for the same by applying Coefficient of Variation (CV).</p><p><strong>Results: </strong>Group B showed better and consistent results in all signs and symptoms except <i>Rukshata, Saparidaha</i> in terms of Coefficient of Variation. In both the groups, statistically highly significant improvement was found in signs and symptoms of <i>Shwitra</i> such as <i>Saparidaha, Kandu</i>, size of patches and number of patches; however, the difference between the groups was statistically insignificant.</p><p><strong>Conclusion: </strong>Both the forms (ART, ARG) of <i>Aragvadhadi</i> formulation along with <i>Rasayana Churna</i> were found as a safe and effective treatment in vitiligo with significant pigment regeneration capacity as topical use for application over 2 months.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/78/AYU-42-19.PMC9893897.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9230752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacodynamic appraisal of wound-healing herbs of Sushruta Samhita. 苏hruta Samhita伤口愈合药材的药效学评价。
Ayu
Pub Date : 2021-01-01 Epub Date: 2022-12-07 DOI: 10.4103/ayu.AYU_34_20
Vishal Kumar, Tanuja Manoj Nesari, Shivani Ghildiyal, Rahul Sherkhane
Background: In Sushruta Samhita, various medicinal plants as single and compound formulations having Vrana-Shodhana (wound cleansing) and Vrana-Ropana (wound healing) potential are enumerated. There are no published data available on these wound-healing medicinal plants of Sushruta Samhita. The effectivee management of wound is necessary in the immunocompromised and chronic wounds patients as they take more time to heal. Aim: To review and systematically analyze wound-healing medicinal plants and their modus-operandi on the basis of pharmacodynamics attributes, i.e., Rasa (taste), Veerya (potency), and Vipaka (biotransformation) in the various stages of healing. Materials and methods: Review of Sushruta Samhita was done to gather wound-healing medicinal plants; pharmacodynamics attributes were gatherd from various Nighantus to understand their role in wound healing. The contemporary information about wound-healing mechanism was gathered from PubMed to interpitate the rational use of plants in the various stages of wound healing. Results: The study suggests that 43 medicinal plants have Vrana-Shodhana activity, 48 have Vrana-Ropana and 62 have both Vrana-Shodhana and Vrana-Ropana potential. Medicinal plants with Vrana-Shodhana category are having predominance of Katu (pungent), Tikta (bitter) and Kashaya (astriengent) Rasa. Plants under Vrana-Ropana are having Madhura, Kashaya Rasa (sweet taste), Madhura Vipaka (sweet biotransform) and Sheeta Veerya (cold potency). Conclusion: Plants having Tikta, Kashaya Rasa, Katu Vipaka, and Sheeta Veerya may be useful in the inflammatory stage, plants having Madhura, Kashaya Rasa and Sheeta Veerya may be useful in the prolifiratory stage and plants having Madhura Rasa, Sheeta Veerya, and Madhura Vipaka may be useful in the remodeling stage. The present review will help to give the directions to the researchers for the development of effective wound-healing medicines for wounds.
背景:在Sushruta Samhita中,列举了具有Vrana Shodhana(伤口清洁)和Vrana Ropana(伤口愈合)潜力的各种药用植物作为单一和复合制剂。目前还没有关于苏hruta Samhita的这些伤口愈合药用植物的公开数据。对于免疫功能低下和慢性伤口患者,有效的伤口管理是必要的,因为他们需要更多的时间来愈合。目的:根据药效学属性,即Rasa(味道)、Veerya(效力)和Vipaka(生物转化),回顾和系统分析创伤愈合药用植物及其在不同愈合阶段的作用方式。材料与方法:对山苏药材进行了综述,以收集创伤愈合药用植物;收集了各种Nighantus的药效学属性,以了解它们在伤口愈合中的作用。从PubMed收集了有关伤口愈合机制的当代信息,以促进植物在伤口愈合的各个阶段的合理使用。结果:研究表明,43种药用植物具有Vrana-Shodhana活性,48种具有Vrana Ropana活性,62种同时具有Vrana-Shodhana和Vrana-Ropana潜力。Vrana-Shodhana类药用植物以Katu(辛辣)、Tikta(苦涩)和Kashaya(收敛)Rasa为主。Vrana Ropana下的植物具有Madhura、Kashaya Rasa(甜味)、Madhura Vipaka(甜味生物转化)和Sheeta Veerya(冷效),Sheeta Veerya和Madhura Vipaka可能在重塑阶段有用。本综述将有助于为研究人员开发有效的伤口愈合药物提供指导。
{"title":"Pharmacodynamic appraisal of wound-healing herbs of <i>Sushruta Samhita</i>.","authors":"Vishal Kumar,&nbsp;Tanuja Manoj Nesari,&nbsp;Shivani Ghildiyal,&nbsp;Rahul Sherkhane","doi":"10.4103/ayu.AYU_34_20","DOIUrl":"10.4103/ayu.AYU_34_20","url":null,"abstract":"Background: In Sushruta Samhita, various medicinal plants as single and compound formulations having Vrana-Shodhana (wound cleansing) and Vrana-Ropana (wound healing) potential are enumerated. There are no published data available on these wound-healing medicinal plants of Sushruta Samhita. The effectivee management of wound is necessary in the immunocompromised and chronic wounds patients as they take more time to heal. Aim: To review and systematically analyze wound-healing medicinal plants and their modus-operandi on the basis of pharmacodynamics attributes, i.e., Rasa (taste), Veerya (potency), and Vipaka (biotransformation) in the various stages of healing. Materials and methods: Review of Sushruta Samhita was done to gather wound-healing medicinal plants; pharmacodynamics attributes were gatherd from various Nighantus to understand their role in wound healing. The contemporary information about wound-healing mechanism was gathered from PubMed to interpitate the rational use of plants in the various stages of wound healing. Results: The study suggests that 43 medicinal plants have Vrana-Shodhana activity, 48 have Vrana-Ropana and 62 have both Vrana-Shodhana and Vrana-Ropana potential. Medicinal plants with Vrana-Shodhana category are having predominance of Katu (pungent), Tikta (bitter) and Kashaya (astriengent) Rasa. Plants under Vrana-Ropana are having Madhura, Kashaya Rasa (sweet taste), Madhura Vipaka (sweet biotransform) and Sheeta Veerya (cold potency). Conclusion: Plants having Tikta, Kashaya Rasa, Katu Vipaka, and Sheeta Veerya may be useful in the inflammatory stage, plants having Madhura, Kashaya Rasa and Sheeta Veerya may be useful in the prolifiratory stage and plants having Madhura Rasa, Sheeta Veerya, and Madhura Vipaka may be useful in the remodeling stage. The present review will help to give the directions to the researchers for the development of effective wound-healing medicines for wounds.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1e/77/AYU-42-1.PMC9893898.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9230750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antifertility effect of methanolic extract of Butea monosperma (Lam.) Taub. flower in male albino rats. Butea monosperma(Lam.)Taub甲醇提取物的抗生育作用。雄性白化大鼠的花朵。
Ayu
Pub Date : 2021-01-01 Epub Date: 2022-12-07 DOI: 10.4103/ayu.AYU_91_20
Shaista Parween, Hena Kausar, Imtiyaz Alam, Shamshun Nehar

Background: Search for an effective, feasible, and safe male contraceptive has been one of the major public health challenges. The present contraceptive methods are either permanent or impractical. Herbal methods are considered safe, and thus, their acceptability is higher than other prospective methods.

Aims: In the present study, oral administration of methanolic extract of Butea monosperma (Lam.) Taub. flower was investigated for its potential role in the modulation of fertility in male albino rats.

Materials and methods: Healthy male albino rats were randomly distributed into three groups, i.e., a control and two groups administered with 50 and 500 mg/kg body weight/day of methanolic extract of B. monosperma flower for 30, 90, and 180 days, respectively. Fertility records were maintained throughout the experimental period. At the end of experiment, animals were sacrificed and the weight of reproductive organs, sperm characteristics, and histopathology of testicular and epididymal tissues were evaluated. A 45-day withdrawal period was also investigated for parameters as described above for each group.

Results: A 40% decline in fertility rate was evident in rats administered with 500 mg/kg of B. monosperma flower extract for 180 consecutive days. A significant reduction in testicular and epididymal weight was observed in these animals. Sperm count, motility, and viability were also reduced significantly in animals treated for 180 days. Histological evaluation of testicular cells indicated distortions in germ cell arrangements at various stages of spermatogenesis. Following 45 days of withdrawal, the resumption of normal functional and histological characteristics was apparent.

Conclusion: Based on the abnormalities present in the sperm characteristics and damages in testicular histology, it was confirmed that methanolic extract of B. monosperma flower contain antifertility potential.

背景:寻找一种有效、可行、安全的男性避孕药一直是公共卫生面临的主要挑战之一。目前的避孕方法要么是永久性的,要么是不切实际的。草药方法被认为是安全的,因此,它们的可接受性高于其他前瞻性方法。目的:在本研究中,口服Butea monosperma(Lam.)Taub的甲醇提取物。研究了花在雄性白化大鼠生殖能力调节中的潜在作用。材料和方法:将健康雄性白化大鼠随机分为三组,即对照组和两组,分别给予50和500mg/kg体重/天的B.monosperma花甲醇提取物30、90和180天。在整个实验期间保持生育记录。实验结束时,处死动物,评估生殖器官的重量、精子特征以及睾丸和附睾组织的组织病理学。还对每组的45天停药期的参数进行了如上所述的研究。结果:在连续180天施用500mg/kg的B.monosperma花提取物的大鼠中,生育率明显下降40%。在这些动物中观察到睾丸和附睾重量显著减少。接受180天治疗的动物精子数量、活力和活力也显著降低。睾丸细胞的组织学评估表明,在精子发生的不同阶段,生殖细胞排列发生了扭曲。停药45天后,恢复了正常的功能和组织学特征。结论:根据精子特征的异常和睾丸组织学损伤,证实单精子花甲醇提取物具有抗生育潜力。
{"title":"Antifertility effect of methanolic extract of <i>Butea monosperma</i> (Lam.) Taub. flower in male albino rats.","authors":"Shaista Parween,&nbsp;Hena Kausar,&nbsp;Imtiyaz Alam,&nbsp;Shamshun Nehar","doi":"10.4103/ayu.AYU_91_20","DOIUrl":"10.4103/ayu.AYU_91_20","url":null,"abstract":"<p><strong>Background: </strong>Search for an effective, feasible, and safe male contraceptive has been one of the major public health challenges. The present contraceptive methods are either permanent or impractical. Herbal methods are considered safe, and thus, their acceptability is higher than other prospective methods.</p><p><strong>Aims: </strong>In the present study, oral administration of methanolic extract of <i>Butea monosperma</i> (Lam.) Taub. flower was investigated for its potential role in the modulation of fertility in male albino rats.</p><p><strong>Materials and methods: </strong>Healthy male albino rats were randomly distributed into three groups, i.e., a control and two groups administered with 50 and 500 mg/kg body weight/day of methanolic extract of <i>B. monosperma</i> flower for 30, 90, and 180 days, respectively. Fertility records were maintained throughout the experimental period. At the end of experiment, animals were sacrificed and the weight of reproductive organs, sperm characteristics, and histopathology of testicular and epididymal tissues were evaluated. A 45-day withdrawal period was also investigated for parameters as described above for each group.</p><p><strong>Results: </strong>A 40% decline in fertility rate was evident in rats administered with 500 mg/kg of <i>B. monosperma</i> flower extract for 180 consecutive days. A significant reduction in testicular and epididymal weight was observed in these animals. Sperm count, motility, and viability were also reduced significantly in animals treated for 180 days. Histological evaluation of testicular cells indicated distortions in germ cell arrangements at various stages of spermatogenesis. Following 45 days of withdrawal, the resumption of normal functional and histological characteristics was apparent.</p><p><strong>Conclusion: </strong>Based on the abnormalities present in the sperm characteristics and damages in testicular histology, it was confirmed that methanolic extract of <i>B. monosperma</i> flower contain antifertility potential.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dd/f4/AYU-42-57.PMC9893902.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9230753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of diet supplemented with Lepidium sativum (Chandrashoor) on expressed breast milk volume in hypogalactic mothers - An open-label noncross-over randomized trial. 添加Lepidium sativum(Chandrashoor)的饮食对低乳糖母亲母乳表达量的影响——一项开放标签非交叉随机试验。
Ayu
Pub Date : 2021-01-01 Epub Date: 2022-12-07 DOI: 10.4103/ayu.ayu_457_20
Manjiri Ranade, Nikhil Mudgalkar

Background: Hypogalactia is the common condition, especially in preterm deliveries. Some herbs in Indian medicines such as Lepidium sativum L. (L. sativum) have galactogogeus effects. The galactogogeus effect of L. sativum (Chandrashoora) has not been quantified in randomized control trials in humans till date. We intend to study the galactogogeus effects of L. sativum in hypogalactic mothers through an open-label noncross-over trial.

Materials and methods: The target population were women who had delivered infants <32 weeks gestation with no lower limit to gestational age and their babies admitted in neonatal intensive care unit for prematurity. Participants who were taking specific drugs as a result of their primary illnesses, such as chemotherapy, sedatives, or antiseziure medications, were excluded. The randomization was achieved with computer-generated random number table. The experimental group (n = 23) received 2.5 g of L. sativum (Chandrashoora) seeds each day, soaked in luke warm water for half an hour in the morning, along with instructions about how to take the seeds. The control group did not receive any medication (n = 23). According to the institutional procedure, participants were trained to express breast milk six times using a breast pump. The amount of milk extracted was measured every day for 28 days. The difference in milk production between the two groups at 28 days was the primary endpoint. The secondary endpoint was to asses if any of the trial medicines had any adverse drug effects.

Results: A total of 46 participants completed the study till 28 days. In both groups, demographic factors were comparable. The study group surpassed the control group in terms of breast milk volume slowly and reached statistical significance (P = 0.00002) after 28 days of therapy. No adverse drug effects were reported by the participants.

Conclusion: There was statistically significant improvement in breast milk production at 28 days in hypogalactic mothers in the experimental group. L. sativum can be used as cheap alternatives to costly medicines to improve lactation with minimal costs and no adverse drug reactions.

背景:低血糖是一种常见的情况,尤其是在早产中。印度药物中的一些草药,如Lepidium sativum L.(L.sativum)具有促乳作用。迄今为止,L.sativum(Chandrashoora)的促乳作用尚未在人类随机对照试验中量化。我们打算通过一项开放标签的非交叉试验来研究L.sativum对低乳糖母亲的促乳作用。材料和方法:目标人群是分娩的女性(n=23),每天接受2.5克L.sativum(Chandrashoora)种子,早上在卢克温水中浸泡半小时,并说明如何服用种子。对照组未接受任何药物治疗(n=23)。根据机构程序,参与者接受了使用吸奶器吸奶六次的培训。在28天内每天测量提取的牛奶量。两组在第28天的产奶量差异是主要终点。次要终点是评估试验药物是否有任何不良药物作用。结果:共有46名参与者完成了研究,直到28天。在两组中,人口统计学因素具有可比性。研究组在母乳量方面缓慢超过对照组,并在治疗28天后达到统计学意义(P=0.0002)。参与者未报告药物不良反应。结论:实验组在28天时,低血糖母亲的母乳产量有统计学意义的改善。L.sativum可以作为昂贵药物的廉价替代品,以最低的成本改善泌乳,并且没有不良药物反应。
{"title":"The efficacy of diet supplemented with <i>Lepidium sativum (Chandrashoor)</i> on expressed breast milk volume in hypogalactic mothers - An open-label noncross-over randomized trial.","authors":"Manjiri Ranade,&nbsp;Nikhil Mudgalkar","doi":"10.4103/ayu.ayu_457_20","DOIUrl":"10.4103/ayu.ayu_457_20","url":null,"abstract":"<p><strong>Background: </strong>Hypogalactia is the common condition, especially in preterm deliveries. Some herbs in Indian medicines such as <i>Lepidium sativum L.</i> (<i>L. sativum</i>) have galactogogeus effects. The galactogogeus effect of <i>L. sativum (Chandrashoora)</i> has not been quantified in randomized control trials in humans till date. We intend to study the galactogogeus effects of <i>L. sativum</i> in hypogalactic mothers through an open-label noncross-over trial.</p><p><strong>Materials and methods: </strong>The target population were women who had delivered infants <32 weeks gestation with no lower limit to gestational age and their babies admitted in neonatal intensive care unit for prematurity. Participants who were taking specific drugs as a result of their primary illnesses, such as chemotherapy, sedatives, or antiseziure medications, were excluded. The randomization was achieved with computer-generated random number table. The experimental group (<i>n</i> = 23) received 2.5 g of <i>L. sativum (Chandrashoora</i>) seeds each day, soaked in luke warm water for half an hour in the morning, along with instructions about how to take the seeds. The control group did not receive any medication (<i>n</i> = 23). According to the institutional procedure, participants were trained to express breast milk six times using a breast pump. The amount of milk extracted was measured every day for 28 days. The difference in milk production between the two groups at 28 days was the primary endpoint. The secondary endpoint was to asses if any of the trial medicines had any adverse drug effects.</p><p><strong>Results: </strong>A total of 46 participants completed the study till 28 days. In both groups, demographic factors were comparable. The study group surpassed the control group in terms of breast milk volume slowly and reached statistical significance (<i>P</i> = 0.00002) after 28 days of therapy. No adverse drug effects were reported by the participants.</p><p><strong>Conclusion: </strong>There was statistically significant improvement in breast milk production at 28 days in hypogalactic mothers in the experimental group. <i>L. sativum</i> can be used as cheap alternatives to costly medicines to improve lactation with minimal costs and no adverse drug reactions.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/22/AYU-42-35.PMC9893899.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10663215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative diuretic evaluation of fruit and root of Gokshura (Tribulus terrestris Linn.) in albino rats. 对白化病大鼠服用附子果实和根的利尿作用的比较评价。
Ayu
Pub Date : 2021-01-01 Epub Date: 2022-12-07 DOI: 10.4103/ayu.AYU_154_17
Ankitha Sudheendran, M A Shajahan, S Premlal

Background: Gokshura Moola (root of Tribulus terrestris Linn.) is one among the ingredients of Dashamoola, a group of ten medicinal plants principally comprising roots as the useful part. In practice instead of root, fruit of Gokshura is widely used in most of the preparations of Dashamoola in Kerala. Dashamoola occupies a significant role in a wide range of Ayurvedic formulations and holds a major share in the drug manufacturing industry. This high demand of Dashamoola, leads the use of fruit instead of its root and implies the need to compare the efficacy of root and fruit of Gokshura.

Aim: This study is planned to assess whether fruit of Gokshura can be substituted for its root using the parameter of diuretic activity in Wistar albino rats.

Materials and methods: Wistar albino rats were divided in to four groups. The group I control group and group II standard group was orally administered with carboxymethyl cellulose 2% in normal saline and furosemide (20 mg/kg) respectively. Group III was administered orally with decoction of Gokshura root and groups IV with Gokshura fruit decoction, with a dose of 8.64 ml/kg. The diuretic effect was evaluated by measuring urine volume, Na+, K+ and Cl- ion content in urine. The results were analyzed by applying one-way ANOVA and LSD Post hoc pairwise comparison test.

Results: Both test drugs in group III and group IV provided significant increase in urine output when compared to the control group (P < 0.001). Decoction of Gokshura root provided a significant increase in comparison to decoction of Gokshura fruit in regards of sodium (P < 0.01), potassium (P < 0.001), and chloride ion (P < 0.05) excretion.

Conclusion: Diuretic action of both root and fruit of Gokshura is similar in terms of urine volume, but root is more effective in the basis of ionic excretion. Hence, while treating patients suffering from ionic imbalance, it is better to use fruit of Gokshura for protecting the ionic balance during diuresis. In all other conditions, root can be used for a better diuretic activity.

背景:珙桐(Tribulus terrestris Linn.的根)是大花木属的一种成分,大花木是由10种药用植物组成的一组,主要由根作为有用部分。实际上,在喀拉拉邦的大部分达沙穆拉制剂中,都广泛使用了番石榴果实代替根。Dashamoula在阿育吠陀的各种配方中发挥着重要作用,并在药品制造业中占有重要份额。这种对Dashamoula的高需求,导致使用水果而不是其根,并意味着需要比较其根和果实的功效。目的:本研究旨在利用Wistar白化大鼠的利尿活性参数来评估附子是否可以代替附子的根。材料与方法:将Wistar白化大鼠分为四组。第一组对照组和第二组标准组分别口服2%羧甲基纤维素生理盐水和速尿(20mg/kg)。第三组口服黄芪汤,第四组口服黄芪果汤,剂量8.64ml/kg。通过测定尿量、尿中Na+、K+和Cl-离子含量来评价其利尿作用。采用单因素方差分析和LSD事后配对比较检验对结果进行分析。结果:与对照组相比,第三组和第四组的受试药物的尿量均显著增加(P<0.001)。在钠(P<0.01)、钾(P<001)和氯离子(P<0.05)的排泄方面,苍术根汤与苍术果汤相比有显著增加。结论:在尿量方面,附子和附子的利尿作用相似,但在离子排泄的基础上附子更有效。因此,在治疗离子失衡的患者时,最好使用枸杞子来保护利尿过程中的离子平衡。在所有其他条件下,根可以用于更好的利尿活性。
{"title":"A comparative diuretic evaluation of fruit and root of <i>Gokshura</i> (<i>Tribulus terrestris</i> Linn.) in albino rats.","authors":"Ankitha Sudheendran,&nbsp;M A Shajahan,&nbsp;S Premlal","doi":"10.4103/ayu.AYU_154_17","DOIUrl":"10.4103/ayu.AYU_154_17","url":null,"abstract":"<p><strong>Background: </strong><i>Gokshura Moola</i> (root of <i>Tribulus terrestris</i> Linn.) is one among the ingredients of <i>Dashamoola</i>, a group of ten medicinal plants principally comprising roots as the useful part. In practice instead of root, fruit of <i>Gokshura</i> is widely used in most of the preparations of <i>Dashamoola</i> in Kerala. <i>Dashamoola</i> occupies a significant role in a wide range of Ayurvedic formulations and holds a major share in the drug manufacturing industry. This high demand of <i>Dashamoola</i>, leads the use of fruit instead of its root and implies the need to compare the efficacy of root and fruit of <i>Gokshura</i>.</p><p><strong>Aim: </strong>This study is planned to assess whether fruit of <i>Gokshura</i> can be substituted for its root using the parameter of diuretic activity in Wistar albino rats.</p><p><strong>Materials and methods: </strong>Wistar albino rats were divided in to four groups. The group I control group and group II standard group was orally administered with carboxymethyl cellulose 2% in normal saline and furosemide (20 mg/kg) respectively. Group III was administered orally with decoction of <i>Gokshura</i> root and groups IV with <i>Gokshura</i> fruit decoction, with a dose of 8.64 ml/kg. The diuretic effect was evaluated by measuring urine volume, Na<sup>+</sup>, K<sup>+</sup> and Cl<sup>-</sup> ion content in urine. The results were analyzed by applying one-way ANOVA and LSD Post hoc pairwise comparison test.</p><p><strong>Results: </strong>Both test drugs in group III and group IV provided significant increase in urine output when compared to the control group (<i>P</i> < 0.001). Decoction of <i>Gokshura</i> root provided a significant increase in comparison to decoction of <i>Gokshura</i> fruit in regards of sodium (<i>P</i> < 0.01), potassium (<i>P</i> < 0.001), and chloride ion (<i>P</i> < 0.05) excretion.</p><p><strong>Conclusion: </strong>Diuretic action of both root and fruit of <i>Gokshura</i> is similar in terms of urine volume, but root is more effective in the basis of ionic excretion. Hence, while treating patients suffering from ionic imbalance, it is better to use fruit of <i>Gokshura</i> for protecting the ionic balance during diuresis. In all other conditions, root can be used for a better diuretic activity.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/68/f6/AYU-42-52.PMC9893904.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9230747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Vrikshayurveda treatments on physiological attributes and production of diterpenoids in Andrographis paniculata (Burm.f.) Nees. Vrikshayurveda处理对穿心莲生理特性和二萜类化合物产生的评价。
Ayu
Pub Date : 2021-01-01 Epub Date: 2022-12-07 DOI: 10.4103/ayu.ayu_311_21
Gireesh M Ankad, Jagadishchandra Hiremath, Sandeep Ramchandra Pai, Harsha V Hegde

Background: An ancient text on plant life Vrikshayurveda mentions the use of horticulture treatments, Kunapa Jala (KJ) and Panchagavya (PG) (cow milk, cow ghee, cow curd, cow dung, and cow urine) to enhance the efficiency of plants.

Aim: An experiment was conducted to evaluate the effect of KJ and PG application on total leaf area, leaf area index (LAI) leaf area duration (LAD), crop growth rate (CGR), relative growth rate (RGR), and net assimilation rate (NAR); production of andrographolide (A1), neoandrographolide (A2), and 14-deoxy-11,12-didehydroandrographolide (A3) of the Andrographis paniculata (Burm.f.) Nees.

Materials and methods: The experiment was conducted in randomized block design with six treatments, namely control, KJ, PG, farmyard manure, inorganic fertilizer, and humic acid. Simultaneous detection of contents was carried out using reversed-phase-ultra-flow liquid chromatography (RP-UFLC). The parameters were studied at 30, 60, 90, and 120 days after sowing (DAS).

Results: KJ produced higher leaf area and LAI at 90 DAS, LAD between 90 and 120 DAS. PG produced higher CGR, RGR, and NAR between 60 and 90 DAS. RP-UFLC analysis revealed the maximum amount of ingredients at 120 DAS. At this stage, PG treatment recorded the maximum amount of A1, A2, and A3.

Conclusion: Kunapa Jala and Panchagavya treatments were better or at par on physiological parameters and production of diterpenoids of A. paniculata.

背景:一篇关于植物生活的古代文本Vrikshayurvada提到了使用园艺处理,Kunapa Jala(KJ)和Panchagavya(PG)(牛奶、牛酥油、牛凝乳、牛粪和牛尿)来提高植物的效率。目的:评价KJ和PG对总叶面积、叶面积指数(LAI)、叶面积持续时间(LAD)、作物生长率(CGR)、相对生长率(RGR)和净同化率(NAR)的影响;穿心莲内酯(A1)、新穿心莲素(A2)和14-脱氧-11,12-脱氢穿心莲苷(A3)的生产。材料和方法:采用随机区组设计,采用对照、KJ、PG、农家肥、无机肥和腐殖酸六种处理。采用反相超流液相色谱法(RP-UFLC)同时检测含量。结果:KJ在播种后30d、60d、90d和120d具有较高的叶面积和LAI,LAD在90~120das之间。PG在60和90DAS之间产生更高的CGR、RGR和NAR。RP-UFLC分析显示在120 DAS时成分的最大量。在这个阶段,PG处理记录了A1、A2和A3的最大量。结论:Kunapa Jala和Panchagavya处理在圆锥花的生理参数和二萜类化合物的产生方面更好或持平。
{"title":"Evaluation of <i>Vrikshayurveda</i> treatments on physiological attributes and production of diterpenoids in <i>Andrographis paniculata</i> (Burm.f.) Nees.","authors":"Gireesh M Ankad,&nbsp;Jagadishchandra Hiremath,&nbsp;Sandeep Ramchandra Pai,&nbsp;Harsha V Hegde","doi":"10.4103/ayu.ayu_311_21","DOIUrl":"10.4103/ayu.ayu_311_21","url":null,"abstract":"<p><strong>Background: </strong>An ancient text on plant life <i>Vrikshayurveda</i> mentions the use of horticulture treatments, <i>Kunapa Jala</i> (KJ) and <i>Panchagavya</i> (PG) (cow milk, cow ghee, cow curd, cow dung, and cow urine) to enhance the efficiency of plants.</p><p><strong>Aim: </strong>An experiment was conducted to evaluate the effect of KJ and PG application on total leaf area, leaf area index (LAI) leaf area duration (LAD), crop growth rate (CGR), relative growth rate (RGR), and net assimilation rate (NAR); production of andrographolide (A1), neoandrographolide (A2), and 14-deoxy-11,12-didehydroandrographolide (A3) of the <i>Andrographis paniculata</i> (Burm.f.) Nees.</p><p><strong>Materials and methods: </strong>The experiment was conducted in randomized block design with six treatments, namely control, KJ, PG, farmyard manure, inorganic fertilizer, and humic acid. Simultaneous detection of contents was carried out using reversed-phase-ultra-flow liquid chromatography (RP-UFLC). The parameters were studied at 30, 60, 90, and 120 days after sowing (DAS).</p><p><strong>Results: </strong>KJ produced higher leaf area and LAI at 90 DAS, LAD between 90 and 120 DAS. PG produced higher CGR, RGR, and NAR between 60 and 90 DAS. RP-UFLC analysis revealed the maximum amount of ingredients at 120 DAS. At this stage, PG treatment recorded the maximum amount of A1, A2, and A3.</p><p><strong>Conclusion: </strong><i>Kunapa Jala</i> and <i>Panchagavya</i> treatments were better or at par on physiological parameters and production of diterpenoids of <i>A. paniculata</i>.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/82/AYU-42-45.PMC9893900.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10663213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Pandughni Vati & Punarnavadi Mandura Vati in the managment of Pandu w.s.r. iron deficiency anemia in children- An open labelled comparative clinical trial. Pandughni Vati和Punarnavadi Mandura Vati治疗儿童Pandu w.s.r.缺铁性贫血的疗效-一项开放标记的比较临床试验。
Ayu
Pub Date : 2020-10-01 Epub Date: 2022-06-03 DOI: 10.4103/ayu.AYU_206_20
V K Kori, K S Patel

Background: Anemia is a public health problem worldwide, and its prevalence in India is higher than any other south asian countries. Iron deficiency anemia (IDA) is having larger share out of all types of anaemia's. Symptomatology of IDA resembles with Kapha dominant variety of Pandu. Pandughni Vati (PV) and Punarnavadi Mandura (PM) Vati mentioned in Ayurveda are being used in clinical practice since long.

Aim: To assess the efficacy of Pandughni Vati and compare its clinical efficacy with Punarnavadi Mandura Vati in the management of Pandu ws.r. iron deficiency anemia in children.

Materials and methods: Present clinical study was a randomized trial for management of iron deficiency anemia aged 2-16 years. Out of total 91 patients enrolled, 60 completed the study and divided into two groups. In group A, Pandughni Vati (trial drug) and in group B, Punarnavadi Mandura Vati in the management of Pandu ws.r. iron deficiency anemia in children. (standard drug) were given to 30-30 patients respectively for a duration of 90 days in age specific doses. Patients were assessed by clinical signs and symptoms of Pandu and investigation parameters like complete blood count, serum iron, serum ferritin and total iron binding capacity (TIBC) on baseline and after 90 days of treatment. Statistical analysis was carried out by Sigma Stat software.

Results: On comparison, highly significant difference was found between two groups in subjective parameters such as Panduta (pallor), Daurbalya (weakness), Hriddrava (palpitation), Akshikuta Shotha (periorbital oedema), Pindikodweshtana (leg cramps) and Shwasa (breathlessness) whereas objective and saturation percentage except serum ferritin.

Conclusion: The study revealed that, both the drugs; Pandughni Vati and Punarnavadi Mandura Vati were equally effective in the management of IDA so, it could be concluded that Pandughni Vati, can be used as mineral-free, safe, easily obtainable, palatable, cost-effective alternative drug of choice in alternative of Punarnavadi Mandura in iron deficiency anemia in children.

背景:贫血是一个全球性的公共卫生问题,其在印度的患病率高于任何其他南亚国家。缺铁性贫血(IDA)在所有类型的贫血中所占的比例较大。IDA的症状类似于Kapha优势型Pandu。阿育吠陀中提到的Pandughni Vati (PV)和Punarnavadi Mandura (PM) Vati长期以来一直用于临床实践。目的:评价Pandughni Vati的疗效,并比较其与Punarnavadi Mandura Vati治疗Pandu wr的临床疗效。儿童缺铁性贫血。材料和方法:本临床研究是一项2-16岁儿童缺铁性贫血治疗的随机试验。在总共91名入组患者中,60名完成了研究并被分为两组。A组使用Pandughni Vati(试验药物),B组使用Punarnavadi Mandura Vati治疗Pandu。儿童缺铁性贫血。(标准药物)分别给予30-30例患者,按年龄给药,疗程90天。在治疗前和治疗90 d后,通过Pandu的临床体征和症状以及全血细胞计数、血清铁、血清铁蛋白和总铁结合能力(TIBC)等调查参数对患者进行评估。采用Sigma Stat软件进行统计分析。结果:两组患者除血清铁蛋白外,在主观指标Panduta(苍白)、Daurbalya(虚弱)、Hriddrava(心悸)、Akshikuta Shotha(眶周水肿)、Pindikodweshtana(腿部痉挛)、Shwasa(呼吸困难)等方面均存在显著差异。结论:研究表明,两种药物;Pandughni Vati和Punarnavadi Mandura Vati对IDA的治疗效果相同,因此,Pandughni Vati可以作为无矿物质、安全、易于获得、可口、经济的替代药物,作为Punarnavadi Mandura的替代药物,用于儿童缺铁性贫血。
{"title":"Efficacy of <i>Pandughni Vati</i> & <i>Punarnavadi Mandura Vati</i> in the managment of <i>Pandu</i> w.s.r. iron deficiency anemia in children- An open labelled comparative clinical trial.","authors":"V K Kori,&nbsp;K S Patel","doi":"10.4103/ayu.AYU_206_20","DOIUrl":"https://doi.org/10.4103/ayu.AYU_206_20","url":null,"abstract":"<p><strong>Background: </strong>Anemia is a public health problem worldwide, and its prevalence in India is higher than any other south asian countries. Iron deficiency anemia (IDA) is having larger share out of all types of anaemia's. Symptomatology of IDA resembles with <i>Kapha</i> dominant variety of <i>Pandu</i>. <i>Pandughni</i> <i>Vati</i> (PV) and <i>Punarnavadi</i> <i>Mandura</i> (PM) <i>Vati</i> mentioned in Ayurveda are being used in clinical practice since long.</p><p><strong>Aim: </strong>To assess the efficacy of <i>Pandughni</i> <i>Vati</i> and compare its clinical efficacy with <i>Punarnavadi Mandura Vati</i> in the management of <i>Pandu</i> ws.r. iron deficiency anemia in children.</p><p><strong>Materials and methods: </strong>Present clinical study was a randomized trial for management of iron deficiency anemia aged 2-16 years. Out of total 91 patients enrolled, 60 completed the study and divided into two groups. In group A, <i>Pandughni Vati</i> (trial drug) and in group B, <i>Punarnavadi Mandura Vati</i> in the management of <i>Pandu</i> ws.r. iron deficiency anemia in children. (standard drug) were given to 30-30 patients respectively for a duration of 90 days in age specific doses. Patients were assessed by clinical signs and symptoms of <i>Pandu</i> and investigation parameters like complete blood count, serum iron, serum ferritin and total iron binding capacity (TIBC) on baseline and after 90 days of treatment. Statistical analysis was carried out by Sigma Stat software.</p><p><strong>Results: </strong>On comparison, highly significant difference was found between two groups in subjective parameters such as <i>Panduta</i> (pallor), <i>Daurbalya</i> (weakness), <i>Hriddrava</i> (palpitation), <i>Akshikuta Shotha</i> (periorbital oedema), <i>Pindikodweshtana</i> (leg cramps) and <i>Shwasa</i> (breathlessness) whereas objective and saturation percentage except serum ferritin.</p><p><strong>Conclusion: </strong>The study revealed that, both the drugs; <i>Pandughni Vati</i> and <i>Punarnavadi Mandura Vati</i> were equally effective in the management of IDA so, it could be concluded that <i>Pandughni Vati</i>, can be used as mineral-free, safe, easily obtainable, palatable, cost-effective alternative drug of choice in alternative of <i>Punarnavadi Mandura</i> in iron deficiency anemia in children.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/4a/AYU-41-218.PMC9261995.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40489989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization and antimicrobial study of Trinakantamani (Amber) Pishti. trakantamani (Amber) Pishti的鉴定及抗菌研究。
Ayu
Pub Date : 2020-10-01 Epub Date: 2022-06-03 DOI: 10.4103/ayu.AYU_155_19
Namrata Joshi, Meena Rani Ahuja, Gopal Krishan Rastogi, Manoj Kumar Dash

Background: Trinakantamani Pishti (TMP) is a cardio-tonic (Hridya), styptic (Rakta Stambhaka), astringent (Kashaya) formulation frequently used in varieties of bleeding disorders such as bloody diarrhea (Raktatisaara), Raktarsha (bleeding piles), and disorders of excessive menstruation (Atyartava). Still, no published data is available regarding its characterization.

Aim: To generate a fingerprint for raw and processed TMP using sophisticated instrumental techniques to assess antimicrobial activity of TMP.

Materials and methods: Three samples of TMP were prepared using the standard reference method. Characterization of TMP was carried out by Fourier-transform infrared spectroscopy (FTIR), energy dispersive X-ray analysis (EDEX) with scanning electron microscopy, powder X-ray diffraction (XRD). Antibacterial activity was carried out by the well-diffusion method.

Results: Analysis by scanning electron microscope revealed maximum particle size <5 μm and <3 μm in the raw sample and TMP, respectively. Minimum particle size in TMP ranges from 1 to 2 μm and 701 nm. EDEX analysis shows carbon and oxygen as major constituents while Na, Mg, Ca, Si, Fe, and S were present in traces. XRD pattern indicates the amorphous nature of the drug, while FTIR analysis reveals the presence of functional groups such as O-H, CO2, C = O, C-N, N-H. Heavy metals, total microbial count, and microbial limit test were found to be under permissible limits. Anti-microbial study against tested pathogens Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Salmonella typhimurium did not show any effect of TMP.

Conclusion: The results of EDEX study showed that Pishti samples have the small particle size i.e., 701nm than the raw i.e., 1-2 μm, which may facillitate absobtion of drug into the body. All heavy metals in the samples were within the permissible limit. Carbon, hydrogen and oxygen are the chief elements of drug which confirms similarity to the Amber, Since the present work is the first published literature on characterization and anti-microbial study on TMP, the outcome can be considered as fingerprint for the drug prepared using the mentioned reference method.

背景:Trinakantamani Pishti (TMP)是一种强心剂(Hridya),止血剂(Rakta Stambhaka),收敛剂(Kashaya)配方,经常用于各种出血性疾病,如血性腹泻(Raktatisaara),出血堆(Raktarsha)和月经过多(Atyartava)。不过,目前还没有关于其特征的公开数据。目的:利用先进的仪器技术建立川芎嗪生药和炮制品的指纹图谱,以评价川芎嗪的抗菌活性。材料与方法:采用标准参比法制备三份TMP样品。采用傅里叶变换红外光谱(FTIR)、扫描电镜能谱分析(EDEX)、粉末x射线衍射(XRD)对TMP进行表征。采用孔扩散法测定其抑菌活性。结果:经扫描电镜分析,最大粒径金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌和鼠伤寒沙门菌未见TMP作用。结论:EDEX实验结果表明,Pishti样品的粒径比原料药的1 ~ 2 μm小,约为701nm,有利于药物在体内的吸收。样品中重金属含量均在允许范围内。碳、氢和氧是药物的主要元素,与琥珀相似,由于本工作是首次发表的关于TMP的表征和抗菌研究的文献,因此该结果可以作为采用上述参考方法制备的药物的指纹。
{"title":"Characterization and antimicrobial study of <i>Trinakantamani (Amber</i>) <i>Pishti</i>.","authors":"Namrata Joshi,&nbsp;Meena Rani Ahuja,&nbsp;Gopal Krishan Rastogi,&nbsp;Manoj Kumar Dash","doi":"10.4103/ayu.AYU_155_19","DOIUrl":"https://doi.org/10.4103/ayu.AYU_155_19","url":null,"abstract":"<p><strong>Background: </strong><i>Trinakantamani</i> <i>Pishti</i> (TMP) is a cardio-tonic (<i>Hridya</i>), styptic (<i>Rakta</i> <i>Stambhaka</i>), astringent (<i>Kashaya</i>) formulation frequently used in varieties of bleeding disorders such as bloody diarrhea (<i>Raktatisaara</i>), <i>Raktarsha</i> (bleeding piles), and disorders of excessive menstruation (<i>Atyartava</i>). Still, no published data is available regarding its characterization.</p><p><strong>Aim: </strong>To generate a fingerprint for raw and processed TMP using sophisticated instrumental techniques to assess antimicrobial activity of TMP.</p><p><strong>Materials and methods: </strong>Three samples of TMP were prepared using the standard reference method. Characterization of TMP was carried out by Fourier-transform infrared spectroscopy (FTIR), energy dispersive X-ray analysis (EDEX) with scanning electron microscopy, powder X-ray diffraction (XRD)<b>.</b> Antibacterial activity was carried out by the well-diffusion method.</p><p><strong>Results: </strong>Analysis by scanning electron microscope revealed maximum particle size <5 μm and <3 μm in the raw sample and TMP, respectively. Minimum particle size in TMP ranges from 1 to 2 μm and 701 nm. EDEX analysis shows carbon and oxygen as major constituents while Na, Mg, Ca, Si, Fe, and S were present in traces. XRD pattern indicates the amorphous nature of the drug, while FTIR analysis reveals the presence of functional groups such as O-H, CO2, C = O, C-N, N-H. Heavy metals, total microbial count, and microbial limit test were found to be under permissible limits. Anti-microbial study against tested pathogens <i>Staphylococcus</i> <i>aureus</i>, <i>Escherichia</i> <i>coli</i>, <i>Pseudomonas</i> <i>aeruginosa</i> and <i>Salmonella</i> <i>typhimurium</i> did not show any effect of TMP.</p><p><strong>Conclusion: </strong>The results of EDEX study showed that <i>Pishti</i> samples have the small particle size i.e., 701nm than the raw i.e., 1-2 μm, which may facillitate absobtion of drug into the body. All heavy metals in the samples were within the permissible limit. Carbon, hydrogen and oxygen are the chief elements of drug which confirms similarity to the <i>Amber</i>, Since the present work is the first published literature on characterization and anti-microbial study on TMP, the outcome can be considered as fingerprint for the drug prepared using the mentioned reference method.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/40/AYU-41-225.PMC9261990.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40489990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenolic composition, antioxidant and anti-fibrotic effects of Sesbania grandiflora L. (Agastya) - An edible medicinal plant. 药用植物大田菁的酚类成分、抗氧化和抗纤维化作用。
Ayu
Pub Date : 2020-10-01 Epub Date: 2022-06-03 DOI: 10.4103/ayu.AYU_198_19
Saravanakumar Arthanari, Parthiban Periyasamy

Background: Sesbania grandiflora (S. grandiflora/Agastya) is an edible Indian traditional medicinal plant widely used as dietary supplements and possesses various pharmacological activities.

Aims: The aim is to evaluate aqueous ethanol extract of S. grandiflora leaves and flowers for its anti-oxidant and anti-proliferative and anti-fibrotic effects using activated rat hepatic stellate cell (HSC)-T6.

Material and methods: The antioxidant activities of these plant extracts were assessed as per the standard methods and the total phenolic and flavonoid contents were examined by folin ciocalteu reagent and colorimetric methods respectively. The anti-proliferation assay was conducted by using a cyto X cell viability assay kit. The anti-fibrotic effect was investigated by measuring the hydroxyproline content and gene expression analysis of the two main fibrogenic cytokines in activated HSC-T6 cells: Transforming growth factor-beta (TGF-β) and alpha-smooth muscle actin (α-SMA).

Results: The aqueous ethanol extract of S. grandiflora leaves showed the highest antioxidant activity in a concentration-dependent manner. These findings were well correlated with the total phenols and flavonoids contents. The aqueous ethanol extract of S. grandiflora leaf and flower significantly reduced the proliferation of activated HSC-T6 cells. Regarding the anti-fibrotic effect, the hydroxyproline content was significantly reduced in a concentration-dependent manner during the extract treatment. In gene expression analysis, the treatment without extracts drastically up-regulated the fibrogenic cytokines (TGF-β and α-SMA), whereas the treatment with extracts significantly reduced these alterations.

Conclusion: Results of present study revealed the significant antioxidant potential of the aqueous ethanol extract of S. grandiflora leaves and flowers. Among two extracts, S. grandiflora leaves demonstrated greater antioxidant, anti-fibrotic capacity with lower inhibiting concentrations corresponding to 50% values than S. grandiflora flowers.

背景:大田葵是一种可食用的印度传统药用植物,广泛用作膳食补充剂,具有多种药理活性。目的:利用活化的大鼠肝星状细胞(HSC)-T6,评价桔梗叶和花的乙醇水提物的抗氧化、抗增殖和抗纤维化作用。材料与方法:按标准方法测定各植物提取物的抗氧化活性,分别用folin ciocalteu试剂和比色法测定其总酚和总黄酮含量。使用cyto X细胞活力测定试剂盒进行抗增殖试验。通过测定活化的HSC-T6细胞中转化生长因子-β (TGF-β)和α-平滑肌肌动蛋白(α-SMA)两种主要纤维化细胞因子的羟脯氨酸含量和基因表达分析,研究其抗纤维化作用。结果:桔梗叶乙醇水提物的抗氧化活性最高,且呈浓度依赖性。这些结果与总酚和总黄酮含量有良好的相关性。桔梗叶和花的乙醇水提物显著降低了活化的HSC-T6细胞的增殖。在抗纤维化作用方面,在提取物处理过程中,羟脯氨酸含量呈浓度依赖性显著降低。在基因表达分析中,无提取物处理显著上调了纤维原性细胞因子(TGF-β和α-SMA),而提取物处理显著降低了这些变化。结论:桔梗叶和花的乙醇水提物具有较强的抗氧化活性。在两种提取物中,大花梗叶的抗氧化和抗纤维化能力较强,抑制浓度比大花梗低50%。
{"title":"Phenolic composition, antioxidant and anti-fibrotic effects of <i>Sesbania grandiflora</i> L. (<i>Agastya</i>) - An edible medicinal plant.","authors":"Saravanakumar Arthanari,&nbsp;Parthiban Periyasamy","doi":"10.4103/ayu.AYU_198_19","DOIUrl":"https://doi.org/10.4103/ayu.AYU_198_19","url":null,"abstract":"<p><strong>Background: </strong><i>Sesbania</i> <i>grandiflora</i> (<i>S</i>. <i>grandiflora</i>/<i>Agastya</i>) is an edible Indian traditional medicinal plant widely used as dietary supplements and possesses various pharmacological activities.</p><p><strong>Aims: </strong>The aim is to evaluate aqueous ethanol extract of <i>S</i>. <i>grandiflora</i> leaves and flowers for its anti-oxidant and anti-proliferative and anti-fibrotic effects using activated rat hepatic stellate cell (HSC)-T6.</p><p><strong>Material and methods: </strong>The antioxidant activities of these plant extracts were assessed as per the standard methods and the total phenolic and flavonoid contents were examined by folin ciocalteu reagent and colorimetric methods respectively. The anti-proliferation assay was conducted by using a cyto X cell viability assay kit. The anti-fibrotic effect was investigated by measuring the hydroxyproline content and gene expression analysis of the two main fibrogenic cytokines in activated HSC-T6 cells: Transforming growth factor-beta (TGF-β) and alpha-smooth muscle actin (α-SMA).</p><p><strong>Results: </strong>The aqueous ethanol extract of <i>S</i>. <i>grandiflora</i> leaves showed the highest antioxidant activity in a concentration-dependent manner. These findings were well correlated with the total phenols and flavonoids contents. The aqueous ethanol extract of <i>S</i>. <i>grandiflora</i> leaf and flower significantly reduced the proliferation of activated HSC-T6 cells. Regarding the anti-fibrotic effect, the hydroxyproline content was significantly reduced in a concentration-dependent manner during the extract treatment. In gene expression analysis, the treatment without extracts drastically up-regulated the fibrogenic cytokines (TGF-β and α-SMA), whereas the treatment with extracts significantly reduced these alterations.</p><p><strong>Conclusion: </strong>Results of present study revealed the significant antioxidant potential of the aqueous ethanol extract of <i>S</i>. <i>grandiflora</i> leaves and flowers. Among two extracts, <i>S</i>. <i>grandiflora</i> leaves demonstrated greater antioxidant, anti-fibrotic capacity with lower inhibiting concentrations corresponding to 50% values than <i>S</i>. <i>grandiflora</i> flowers.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/b6/AYU-41-242.PMC9261989.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40490430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ayu
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1